Načítá se...
Alternative Splicing in CKD
Alternative splicing (AS) has emerged in the postgenomic era as one of the main drivers of proteome diversity, with ≥94% of multiexon genes alternatively spliced in humans. AS is therefore one of the main control mechanisms for cell phenotype, and is a process deregulated in disease. Numerous report...
Uloženo v:
| Vydáno v: | J Am Soc Nephrol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884122/ https://ncbi.nlm.nih.gov/pubmed/26763787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015080908 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|